Jules A. Maltz - May 12, 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Soleil Boughton, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
May 12, 2022
Transactions value $
$0
Form type
4
Date filed
5/16/2022, 08:58 PM
Previous filing
Mar 17, 2022
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Other +9.21K +48.46% 28.2K May 12, 2022 Direct F1
holding HIMS Class A Common Stock 54K May 12, 2022 Held by Institutional Venture Partners XV Executive Fund, L.P. F2
holding HIMS Class A Common Stock 10.1M May 12, 2022 Held by Institutional Venture Partners XV, L.P. F2
holding HIMS Class A Common Stock 10.2M May 12, 2022 Held by Institutional Venture Partners XVI, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b).
F2 Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.